## 

|Contents|||||
|---|---|---|---|---|
|||||Page number|
|Chair's Report|||||
|Trustees Report (Incorporating<br>Directors' and|||Strategic Reports)||
|The Covid-19 pandemic —ayear||like no other|||
|Our Income in 2020rr21|||||
|How we spent our money 2020/21|||||
|The people we help —Kevin's story||||12|
|What we' ve achieved|this year|||13|
|How we achieved<br>it|||||
|What we haven't achieved||||20|
|Looking forward||||21|
|Structure, Governance|and Management|||24|
|State ment ofTrustees'|Responsibilities<br>for the||||
|Financial Statements|and Corporate Governance||||
|Independent<br>Auditors'|report to the members||of|34|
|Tenovus Cancer Care|||||
|Financial Statements||||37|
|Notes to the financial statements||for the year ended 31"March 2021||42|
|We wanted to thank|||||





## 



## 



## 



## 




## 

## 



## 



## 



## 



## 




## 





## 



## 

## 

## 



## 

## 

## 



## 



## 



## 

## 



## 

## 



## 

## 

## 



## 

## 



## 

## 

## 

## 



## 



## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 



## 

## 



## 



## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



Tenovus Cancw C3reA•walRepori & Accounts | YearEnding 31% March 2021
36
A fijrther description of our responsibilities Is available on the FinanciaL Reporting Council s website at..
httpxllwww.frLofg.uklOui-WothlAvditlAudit-and-assurancelStandards-and-widancelStandards-and-
gvldancfrfor-auditorslAuditOts-responsibllities-for-auditlDe5UiPtion-of-auditOfS-responsibiiities-for-
audiLasp
This description form5 part of our auditor's report
Extent to which the audit was considered cap(thle of detecting irregularities,
including fraud
Irregul2rFties, including fravd, are instances of non-coMp￿ance with laws and regulations. We deslgn
procedures In ￿ne with our respon5ibiUties, outLined above and on the Financial Reporting CounciL's
website, to detect materiaL misstatements in respect of Irregularities. Including fraud.
We obtain and update our understanding of t￿ entity, its activities, its control envIron￿￿￿t and likely
future developments, incLuding in reLation to the LegaL and regulatory framework appbcabLe and the
entity is complying with tlk2t framework. Based on this understanding. we identify and assess the risks
of material misstatement of the financiaL statement5, whether due to fraud or error, design and perform
audit Pro￿dureS responsive to those risks. and obtain audlt evldence that is sufficient and appropriate
to provide a basis for our opinion. This incLude5 consideration of the risk of acts by the entity that were
contrary to applicable Laws and reguLatlons, incLuding fraud.
In response to the risk of irregJLaritles and non-compLiance with laws and regulations. InclL￿lng fraud. we
deslgned procedures which inciLxled:
Enquiry of management and those charged wlth govemance around actual and potential Iltlgation and
cLaims as welL as actuaL 5uspetted and aiieged fraud.,
Reviewing minutes of meetlngs of those charged with governance:
Assessing extent of comptiance wlth the Laws and reguLations considered to have a direct materlaL
effect on the financial statements or the operations of the entity fvough enquiry and inspectlon,.
Reviewing financlaL statement discl05ures and testing to supporting documentation to assess
Comp￿ance with appLicabLe laws and reguL8tions',
Performing audit work over t￿ risk of managempnt bias and override of controls, including testing
of journal entries and other adjustments for approprlateness, evaluating the business rationaLe of
significant transactions outside ￿ nor￿[ course of business and reviewing accounting estlmates for
indicators of potential bias.
Because of the Intr￿ent Umitatlons of an audit, tlEre is a risk that we WILL not detect ali irregularities.
including t￿)Se Leading to a material misstatement in the financiaL statements or non-compliance with
reguLition. This risk increases the more that compliance with a law or reguLation is removed from the
events and transartions refiected in the financial State￿￿ntS, as we will be less Likely to become aware
of instances of non-compliance. The rlsk of not detecting a materiaL misstatement resuLting from fraud
Is hlgher than for one ￿SuLt1rKj from error, as fraud may invoLve coLLuslon, forgery, Intentional omissions,
misrepresentations, or override of internal control.
Use of our report
This report is made soLeLy to the charitabLe coryary's ff*mbers, as a body. in accordance with Chapter 3
of Part16 of the Companles Act 2006. Our audit work has been undertaken so that we mlght state to the
charitable CoMpa￿S members those matters we are requlred to state to them in an auditor's report and
for no other purpose. To the fuLLest extent permitted by law, we do not accept or assurre ￿SPOnsIblUty to
anyone other than the charitabLe company 3nd the charitsble companls members as a body, for our audit
worK for this repo¢ or for the opinions we have formed.
Sarah Case FCA DthA-1Senior Statutory Auditor)
For and on behalf of Azets Audit Services. Chartered Accoun
Ty Dern. Lime Tree C¢JUrt, Cardlff ￿sIneSS Gate
Cardlff CF23 8AB
nts Statutory Auditor
17-3-2olJ

## 

|xpenditure<br>account and s|tatement|ofrecognised<br>gain|ofrecognised<br>gain|s and losses).|s and losses).|||
|---|---|---|---|---|---|---|---|
||Note|Unrestricted||Restricted||Total 2021|Total 2020|
|||Funds|2021|Funds|2021|||
|||f||f||||
|INCOME &||||||||
|ENDOWMENTS||||||||
|FROM:||||||||
|Donations<br>&Legacies|2|3,315,498||245,159||3,560,657|2,657,701|
|Charitable<br>Activities||||61,931||61,931|178,205|
|Total Fundraising||3,315,498||307,090||3,622,588|2,835,906|
|Income||||||||
|Expenditure||||||||
|Raising funds—||969,884||188,810||1,158,694|1,019,293|
|donations<br>&legacies||||||||
|Total Fundraising||969,884||188,810||1,158,694|1,019,293|
|Expenditure||||||||
|Fundraising||2,345,614||118,280||2,463,894|1,816,613|
|Contribution||||||||
|Job Retention Scheme||||1,250,012||1,250,012||
|Covid Retail Grants||1,032,143||||1,032,143||
|Investment<br>income|||45,440|||45,440|115,112|
|Other income|||||||1,350|
|Total Contribution||3,423,197||1,368,292||4,791,489|1,933,075|
|from Income &||||||||
|Endowments||||||||
|Retail Operations||1,585,340||||1,585,340|5,206,993|
|Trading<br>Income||||||||
|Retail Operations||2,896,589|||825,706|3,722,295|4,696,610|
|Trading<br>Expenditure||||||||
|Contribution<br>from||(1,311,249)||(825,706)||(2,136,955)|510,383|
|Retail Operations||||||||
|Other Trading Activities|||603,165|||603,165|527,906|
|Income||||||||
|Other Trading Activities|||261,313|||261,313|466,753|
|Expenditure||||||||
|Contribution<br>from|||341,852|||341,852|61,153|
|Other Activities||||||||
|Total Contribution||(969,397)||(825,706)||(1,795,103)|571,536|
|from Trading Activities||||||||





|Year Endin<br>31eINsrch 2|02|1||||38|
|---|---|---|---|---|---|---|
|Consolidated<br>Statement|of|Financial|Activities for the year ended 31 March 2021 (incorporating|||income and|
|expenditure<br>account and|statement||of recognised<br>gains and losses) continued.||||
|Net income available for|||2,453,800|542,586|2,996,386|2,504,611|
|Charitable<br>Activities|||||||
|Charitable<br>Expenditure|||||||
|Grants to research||Sa|132,375|36,813|169,188|740,421|
|o<br>anisations|||||||
|Patient Services||Sb|620,815|509,487|1,130,302|1,920,627|
|Sing with Us Support||Sc|281,953|197,952|479,905|624,363|
|Grou s|||||||
|Policy 8 Campaigns||Sd|60,272|9,181|69,453|313,173|
|Total Charitable|||1,095,415|753,433|1,848,848|3,598,584|
|E<br>enditure|||||||
|Net income before|||1,358,385|(210,847)|1,147,538|(1,093,973)|
|(loss) /gain on|||||||
|investments|||||||
|Represented<br>by|||||||
|Total Income|||6,561,586|1,557,102|8,138,688|8,687,267|
|Total Expenditure|||5,223,201|1,767,949|6,991,150|9,781,240|
|Net|||1,358,385|(210,847)|1,147,538|(1,093,973)|
|income/expenditure|||||||
|before (loss) /gain on|||||||
|investments/fixed|||||||
|assets|||||||
|Net (loss) /gain on||16|701,768||701,768|(284,829)|
|investments|||||||
|Transfer between|||3,553|(3,553)|||
|funds|||||||
|Losses on disposal of||13|(28,289)|(2,993)|(31,282)|(534)|
|fixed assets|||||||
|Net movement<br>in funds|||2,035,417|(217,393)|1,818,024|(1,379,336)|
|Reconciliation<br>offunds||21|||||
|Funds brought<br>forward|at||2,950,263|1,257,808|4,208,071|5,587,407|
|1 April 2020|||||||
|Total funds carried||21|4,985,680|1I040,415|6,026,095|4,208,071|
|forward at 31 March|||||||
|2021|||||||





## 

|||||Group||Charity||
|---|---|---|---|---|---|---|---|
||||Note|2021|2020|2021|2020|
|||||6|6||6|
|FIXEDASSETS||||||||
|Tangible assets||||1,543,457|1,895,554|1,543,457|1,895,554|
|Intangible<br>assets|||15|76,268|94,790|76,268|94,790|
|Investments|||16|4,022,759|2,940,386|4,022,759|2,940,386|
|||||5,642,484|4,930,730|5,642,484|4,930,730|
|CURRENT ASSETS||||||||
|Stock|||17|58,789|111,770|||
|Debtors|||18|717,419|1,306,285|805,047|1,289,639|
|Cash at bank and|in|hand||1,048,822|102,242|959,555|24,113|
|||||1,825,030|1,520,297|1,764,602|1,313,752|
|CURRENT LIABILITIES||||||||
|Creditors:<br>amounts||falling|19|(1,137,707)|(1,813,127)|(1,084,630)|(1,616,433)|
|due within one year||||||||
|NET CURRENT||||687,323|(292,830)|679,972|(302,681)|
|ASSETS/(LIABILITIES)||||||||
|Creditors:<br>amounts||falling|19|(303,712)|(429,829)|(303,712)|(429,829)|
|due more than one year||||||||
|TQTAL ASSETS||||6,026,095|4,208,071|6,018,744|4,198,220|
|FUNDS||||||||
|Unrestricted||||||||
|Parent charity||||4,978,329|2,940,412|4,978,329|2,940,412|
|Subsidiary<br>Company|||21|7,351|9,851|||
|Total unrestricted|funds|||4,985,680|2,950,263|4,978,329|2,940,412|
|Restricted||||||||
|Parent charity|||21|1,040,415|1,257,808|1,040,415|1,257,808|
|||||6,026,095|4,208,071|6,018,744|4,198,220|





## 

|||||||2021|2020|
|---|---|---|---|---|---|---|---|
|||||||E|E|
|CASH FLOWS FROM OPERATING||ACTIVITIES||||||
|Net cash provided/<br>(used in) operating||activities||||1,297,916|(34,060)|
|(Noted on Page 41)||||||||
|CASH FLOWS FROM INVESTING|ACTIVITIES:|||||||
|Interest received|||||||241|
|Dividends<br>from investments||||||45,436|114,871|
|Dividends<br>re-invested||||||17,034||
|Proceeds from sale ofinvestments||||||1,961,286|1,662,659|
|Proceeds from sale offixed assets||||||93,633||
|Foreign exchange gains/losses||||||946|(2,305)|
|Purchase oftangible<br>and intangible|assets|||||(51,107)|(988,968)|
|Purchase ofinvestments||||||(2,234,127)|(735,658)|
|NET CASH PROVIDED BYINVESTING ACTIVITIES||||||(166,895)|50,840|
|CASH FLOWS FROM FINANCING|ACTIVITIES:|||||||
|Net change<br>in cash and short term||deposits||(investment||(125,760)|98,896|
|assets)||||||||
|NET CASH FLOWS PROVIDED BY/(USED IN)||||||(125,760)|98,896|
|FINANCING<br>ACTIVITIES||||||||
|Change<br>in cash and cash equivalents|||in the reporting|||1,005,261|115,676|
|period||||||||
|Cash and cash equivalents<br>atthe beginning|||ofthe||reporting|43,561|(72,115)|
|period||||||||
|Cash<br>and cash<br>equivalents<br>at the||end|of the||reporting|1,048,822|43,561|
|period (Note 23)||||||||





|||||||2021f|2020f|
|---|---|---|---|---|---|---|---|
|Net income/(expenditure)|forthe reporting||period before gains||and losses|1~"47538|("093973)|
|on investments<br>and<br>fixed assets||(as|per the statement||of financial|||
|activities)||||||||
|Depreciation/amortisation|oftangible|and|intangible|fixed assets||296,811|253,741|
|Investment<br>income receivable||||||(45,440)|(115,112)|
|(Increase)/decrease<br>in|debtors|||||588,866|771,084|
|Increase/(decrease)<br>in|creditors|||||(742,840)|222,048|
|Decrease/(increase)<br>in|stocks|||||52,981|(71,848)|
|NET CASH USED IN OPERATING||ACTIVITIES (PAGE 40)||||1,297,916|(34,060)|





## 

## 

## 

## 

## 

## 



## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 



## 

## 



|2. DONAT|IONS|& LEG|A|CIES|||||||
|---|---|---|---|---|---|---|---|---|---|---|
||||||||Unrestrictedf|Restrictedf|2021f|2020|
|Donations|& Gifts||||||576,768|9,578|586,346|806,523|
|Legacies|||||||2,579,999|20,678|2,600,675|1,559,675|
|Trusts 8|Grants||||||5,278|214,905|220,183|156,722|
|Donated|Goods|8 Services|||||153,453||153,453|134,781|
||||||||3,315,498|245,159|3,560,657|2,657,701|
|3. CHARITABLE ACTIVITIES|||||||||||
||||||||Unrestricted|Restrictedf|2021f|2020f|
|Welsh Government||||||||||156,079|
|Single Advice Fund||||||||61,931|61,931|22,126|
|||||||||61,931|61,931|178,205|
|4.OTHER|TRADING ACTIVTIES||||||||||
||||||||||2021f|2020f|
|Retail Operations|||||||||||
|Shop income|||||||||1,478,915|5,021,818|
|New Goods||in Trading||Subsidiary||(4a)|||106,425|185,175|
||||||||||1,585,340|5,206,993|
|Other Trading activities|||||||||||
|Mobile|Unit Income||in|Trading|Subsidiary||(4a)||124,024|75,750|
|Contribution||to Mobile||Units within||Charity|||148,680|29,088|
|Events|||||||||29,307|128,294|
|Lottery|||||||||301,154|294,774|
||||||||||603,165|527,906|
||||||||||2,188,505|5,734,899|





||||2021|2020|
|---|---|---|---|---|
|INCOME 6 EXPENDITURE ACCOUNT|||6|6|
|Turnover|||||
|New Goods|||106,425|185,175|
|Mobile Unit|||124,024|75,750|
||||230,449|260,925|
|Net operating|expenses new goods||(145,821)|(144,438)|
|Net operating|expenses mobile unit||(83,833)|(46,822)|
|Operating<br>surplus|||795|69,665|
|Prior year funds|||2,500||
|Amount covenanted||to Tenovus Cancer Care|(3,295)|(69,665)|
|Retained<br>in subsidiary|||||
|A summary<br>of|its aggregate assets, liabilities and funds isas follows:||||
|.Assets|||194;174|252,340|
|Liabilities|||(186,823)|(242,489)|
|Funds|||7,351|9,851|





## 

||||||Unrestrictedf|Unrestrictedf|Unrestrictedf|Restricted|2021<br>6|2020f|
|---|---|---|---|---|---|---|---|---|---|---|
|Dividend<br>income||||||45,436|||45,436|114,871|
|Interest receivable|||||||4||4|241|
|||||||45,440|||45,440|115,112|
|6.EXPENDITURE||FOR RAISING||DONATIONS||LEGACIES||AND|||
|OTHER|||||||||||
||||||Unrestricted|||Restricted|2021|2020|
|||||||6||6|6|6|
|Donations 8 Gifts||(6a)||||595,348||188,810|784,158|697,200|
|Donated goods and services (6b)||||||153,453|||153,453|134,781|
|Legacies and Trusts||||||200,738|||200,738|163,519|
|Investment<br>Management|||Costs|||20,345|||20,345|23,793|
|||||||969,884||188,810|1,158,694|1,019,293|
|6a. DONATIONS||&GIFTS|||Unrestricted|||Restricted|2021|2020|
||||||||6|6||6|
|Staff &other related costs||||||168,956||188,810|357,766|389,335|
|Other overhead|costs|||||43,557|||43,557|71,798|
|Support costs||||||382,835|||382,835|236,067|
|||||||595,348||188,810|784,158|697,200|
|6b.DONATED GOODS|||&SERVICES||Unrestricted|||Restricted|2021|2020|
|||||||6||6|6|6|
|Publicity||||||91,211|||91,211|94,414|
|Mobile<br>Support||Unit|equipment|&||25,000|||25,000|40,000|
|services|||||||||||
|Rent||||||36,875|||36,875||
|Goods &Services||||||367|||367|367|
|||||||153,453|||153,453|134,781|






|||||Unrestricted|Restricted|2021|2020|
|---|---|---|---|---|---|---|---|
|||||Funds|Funds|||
|||||E||||
|7a. RETAIL SHOP COSTS||||||||
|Staff &other related costs||||1,053,716|782,023|1,835,739|2,139,427|
|Rent, rates &insurance||||973,956||973,956|1,132,257|
|Other costs||||133,656|1,200|134,856|357,742|
|Utilities||||82,230||82,230|239,453|
|Consumables|||||||38,624|
|Repairs 8 renewals||||15,828||15,828|119,908|
|Depreciation||||15,937||15,937|19,607|
|Bad debts|||||||35,512|
|Support costs||||475,445|42,483|517,928|469,642|
|||||2,750,768|825,706|3,576,474|4,552,172|
|8.COST OF CHARITABLE ACTIVITIES||||||||
|||||Unrestricted|Restricted|2021|2020|
|||||Funds|Funds|||
|||||E|8|||
|Sa.<br>GRANTS<br>TO|INSTITUTIONAL||RESEARCH|||||
|ORGANISATIONS||||||||
|University<br>of Cardiff||||(10,569)||(10,569)|440,129|
|University<br>ofWales Bangor||||41,206||41,206||
|Swansea Bay UHLB (Lymphoedama||Network Wales)|||||57,000|
|University<br>ofSwansea|||||||37,706|
|Valindre Cancer Care||||(83)||(83)|9,535|
|University cfAberystwylh||||(4,797)||(4,797)|(9,064)|
|CardN &Vale UHB||||(30,000)||(30,000)|(374)|
|Morriston<br>Hospital|||||||(5,883)|
|(managed<br>by Swansea Bay UHLB)||||||||
|Princess ofWales|||||||(590)|
|(managed<br>by Cwm Taf Morgannwg||UHLB)||||||
|Direct costs (sai)||||66,977|31,132|98,109|158,863|
|Support costs (9)||||69,641|5,681|75,322|53,099|
|||||132,375|36,813|169,188|740,421|





|otes to the financial statements|for the year ended 31|March 2021|—continued||
|---|---|---|---|---|
||Unrestricted|Restricted|2021|2020|
||Funds|Funds|||
||f|f|||
|Sai. DIRECT COSTS|||||
|Staff &other related costs|57,342|31,132|88,474|87,961|
|Other research costs|17,126||17,126|49,306|
|Direct overheads|(7,491)||(7,491)|21,596|
||66,977|31,132|98,109|158,863|



|rises. This liability amounted<br>tof407,2|rises. This liability amounted<br>tof407,2|47at 31 March 202|1 (2019/20:f59|7,987).||
|---|---|---|---|---|---|
|8b. PATIENT SERVICES||Unrestricted<br>Fundsf|Restricted<br>Fundsf|2021f|2020f|
|Staff &other related costs||165,713|83,314|249,027|713,005|
|Depreciation||493|16,335|16,828|17,554|
|Direct overhead|costs|1,234|21,856|23,090|110,322|
|Grant|||85,800|85,800||
|Support costs (9)||60,310|31,417|91,727|349,609|
|Mobile Support|Unit direct costs|282,508|261,750|544,258|573,024|
|Mobile Support|Unit support costs (9)|110,557|9,015|119,572|157,113|
|||620,815|509,487|1,130,302|1,920,627|
|8c.SUPPORT GROUPS||||||
|||Unrestricted<br>Funds|Restricted<br>Fundsf|2021f|2020f|
|Staffcosts||94,570|132,818|~227,388|353,936.|
|Direct overhead|costs|15,924|50,561|66,485|49,214|
|Travel &Subsistence|||||24,186|
|Room hire||(7,249)||(7,249)|27,725|
|Support costs (9)||178,708|14,573|193,281|169,302|
|||281,953|197,952|479,905|624,363|
|sd. CAMPAIGNS|&POLICY|||||
|||Unrestricted<br>Fundsf|Restricted<br>Fundsf|2021f|2020f|
|Staff costs||41,249|7,946|49,195|181,383|
|Direct overhead|costs|3,879||3,879|41,007|
|Campaign<br>costs|||||20,724|
|Support costs (9)||15,144|1,235|16,379|70,059|
|||60,272|9,181|69,453|313,173|





## 

||||||||
|---|---|---|---|---|---|---|
|9.SUPPORT COSTS||||||Total|
|||Other overhead|Staff costs|Total|2021|2020|
|||6|||8||
|Retail &Subsidiaries||200,297|363,166|563,463||516,735|
|Costs ofRaising Funds||147,311|267,097|414,408||250,008|
|Patients Services||32,607|59,120|91,727||349,609|
|Mobile Support Units||42,505|77,067|119,572||157,113|
|Support Groups||68,706|124,575|193,281||169,302|
|Campaigns<br>&Policy||5,822|10,557|16,379||70,059|
|Research||26,759|48,563|75,322||53,099|
|||524,007|950,145|1,474,152||1,565,925|
|10.STAFF COSTS AND TRUSTEES'||REMUNERATION|||||
||||2021|||2020|
|||||6||5|
|Wages &salaries|||3,671,848||4,677,203||
|Redundancy<br>&termination|payments||84,336|||73,392|
|Social security costs|||261,989|||368,915|
|Other pension costs (note 24)|||159,243|||201,974|
||||4,177,416|||5,321,484|
|The number<br>of higher paid employees||was as follows:|||||
||||2021|||2020|
||||Number|||Number|
|f60,001 - 870,000|||||||
|f80,001 - K90,000|||||||
|The number of higher paid employees||for whom retirement|benefits are accruing:||||
||||2021|||2020|
||||Number|||Number|
|E60,001 - 870,000|||||||
|F80,001 - 890,000|||||||



||||2021|2020|
|---|---|---|---|---|
||||Number|Number|
|660,001|-|870,000|8,295|17,946|
|f80,001|-|K90,000|6,145|4,994|





## 

## 

|11.STAFF NUMBERS||||||
|---|---|---|---|---|---|
||||2021||2020|
||||Number||Number|
|Average number ofemployees<br>(full time equivalent)||||154|205|
|Patient Services —costs allocated tostatement<br>offinancial activities<br>—patient services||||15|30|
|Research —costs allocated<br>to statement<br>of financial|activities—|||||
|research costs||||||
|Support Groups —costs allocated to statement<br>offinancial activities||||||
|—support groups||||||
|Income Generation<br>Department —allocated to statement <br>activities—|offinancial|||12|17|
|Head Office —allocated to statement<br>offinancial activities||||17|22|
|Campaigns<br>&Policy —allocated to statement<br>offinancial|activities|||1|4|
|Marketing<br>8 Communication<br>—allocated to statement|of financial|||||
|activities||||||
|Shops —allocated to the statement<br>offinancial<br>activities||||97|109|
||||||205|
|12.NET INCOME/ (EXPENDITURE) FOR THE YEAR||||||
|As permitted<br>by Section 230 of the Companies<br>Act 2006,||the parent|company's|income|and expenditure|
|account has not been included<br>in these financial statements.||||||
|The net income/(outgoing)<br>resources for the year are made||up|2021||2020|
|aa follows:|||L'||L|
|Income generated<br>by parent charitable<br>company|||7,908,239||8,426,342|
|Expenditure<br>by parent charitable<br>company||(6,761,496)|||(9,589,980)|
|Share of net<br>income/(expenditure)<br>resources<br>generated||by|795||69,665|
|subsidiary<br>in year and covenanted<br>to this company<br>(Note 4a)||||||
||||1,147,538||(1,093,973)|





## 

|Net incoming|resources|resources|resources|for the|year is stated|year is stated|after|2021||2020|
|---|---|---|---|---|---|---|---|---|---|---|
|charging:||||||||6||6|
|Gift Aid income||||||||69,036||331,179|
|Depreciation<br>of|tangibles|||||||262,479||235,647|
|Amortisation<br>of|Intangibles|||||||34,332||18,094|
|Auditors'<br>remuneration|||—audit fee|||||12,570||12,332|
|Land and buildings||operating<br>lease costs||||||1,063,723|1,141,873||
|Other operating|lease||costs|||||32,768||19,513|
|Profit/(loss)<br>on disposal|||of|tangible fixed assets||||(31,282)||(534)|
|14.TANGIBLE|FIXED||ASSETS||||||||
|Charity &Group|||||||||||
|||Leasehold|||Motor|Furniture,||Mobile Support|Short|TOTAL|
|||shop|||vehicles|fittings &||Units|leasehold||
|||improvements||||equipment|||premises||
|Cost|||||||||||
|At 1 April 2020||||288,990|32,122||398,532|2,407,077|394,602|3,521,323|
|Additions||||34,397|||600|||35,297|
|Disposals||||(84,387)|||(26,517)||(394,602)|(505,506)|
|At 31 March 2021||||239,300|32,122||372,615|2,407,077||3,051,114|
|Depreciation|||||||||||
|At 1 April 2020||||208,226|32,122||303,942|791,777|289,702|1,625,769|
|Charge for the|||||||||||
|year||||17,517|||25,311|203,724|15,927|262,479|
|Eliminated<br>on||||(54,122)|||(20,840)||(305,629)|(380,591)|
|disposal|||||||||||
|At 31March 2021||||171,621|32,122||308,413|995,501||1,507,657|
|Net Book Value||||67,679|||64,202|1,411,576||1,543,457|
|at 31 March 2021|||||||||||
|Net BookValue|at|||80,764|||94,590|1,615,300|104,900|1,895,554|
|31 March 2020|||||||||||





## 

|Charity &Group||||
|---|---|---|---|
|||Software|TOTAL|
|Acquisition<br>Cost||||
|At 1 April 2020||134,506|134,506|
|Additions||15,810|15,810|
|Disposals||||
|At 31 March 2021||150,316|150,316|
|Amortisation||||
|At 1 April 2020||39,716|39,716|
|Charge forthe year||34,332|34,332|
|Eliminated<br>on disposal||||
|At 31 March 2021||74,048|74,048|
|Net Book Value|at 31|76,268|76,268|
|March 2021||||
|Net Book Value|at 31|94,790|94,790|
|Hlarch 2020||||



## 

|FIXEDASSET IN|FIXEDASSET IN|VESTME|NTS|||
|---|---|---|---|---|---|
|Group &Charity||||2021|2020|
|||||6|6|
|Fair value at 1|April 2020|||2,940,386|4,248,823|
|Less: disposals|at|opening|book value|(1,648,757)|(1,604,520)|
|Add:<br>acquisitions||at cost||2,234,127|735,658|
|Net unrealised|investment||gains/(losses)|371,243|(340,681)|
|Increase/(decrease)||in cash as held as part of investment||125,780|(98,894)|
|parffoli||||||
|Fairvalue at 31|March 2021|||4,022,759|2,940,386|





## 



|Notes tothe financial statemen|ts<br>forthe year end|ed<br>31 March 2021<br>co|ntinued|
|---|---|---|---|
|Split by:||||
|Fixed Asset Investments||4,022,759|2,940,386|
|Represented<br>by:||||
|Quoted<br>UK Investments||||
|Fixed Interest Stock, UK Government||55,428|36,136|
|Corporate<br>bond and bond funds||391,328|247,981|
|Equities||2,754,055|1,819,253|
|Other Investments||670,609|811,437|
|Cash held as part ofinvestment|portfolio|151,339|25,579|
|Fair value at 31 March 2021||4,022,759|2,940,386|
|Cost at 31 March 2021||3,492,675|2,995,146|



## 



## 

|||Group|Group|Charity||
|---|---|---|---|---|---|
|||2021|2020|2021|2020|
|||6|E|E|E|
|Greeting cards &merchandise||58,789|111,770|||
|||58,789|111,770|||
|18.DEBTORS||||||
||Group|||Charity||
||2021||2020|2021|2020|
|Amounts<br>falling due within one year:|6||E|E|E|
|Trade debtors|130,028||47,693|93,952|27,077|
|Amount due from subsidiaries||||133,746|45,795|
|Other debtors|14,763||55,852|14,762|55,854|
|Prepayments|363,281||529,146|363,240|529,104|
|Accrued Income|209,347||673,594|199,347|631,809|
||717,419|1,306,285||805,047|1,289,639|
|19.CREDITORS||||||
||Group|||Charity||
||2021||2020|2021|2020|
|Amounts<br>falling due within one year:|6||6|E,|E|
|Bank overdraft|||58,681||58,681|
|Trade creditors|99,163||646,139|99,110|543,390|
|Accruals|624,911||763,254|621,941|760,284|
|Deferred income|133,485||122,790|96,933|46,108|
|Other creditors|280,148||222,263|266,646|207,970|
||1,137,707|1,813,127||1,084,630|1,616,433|



## 



## 

|||||||Group|Group||Charity|Charity||
|---|---|---|---|---|---|---|---|---|---|---|---|
|Amounts|falling|due after one year:||||2021||2020<br>E|2021<br>8||2020<br>f|
|Other creditors||||||303,712||429,829|303,712||429,829|
|||||||303,712||429,829|303,712||429,829|
|ther creditors<br>include the liability for||||repayment|of monies to the Moondance<br>Foundation,<br>research<br>and|||||||
|rant commitments||due after 1 year.|Following||discussions<br>with||Moondance<br>Foundation<br>they|||have|kindly|
|greed to|defer the agreed repayment|||schedule|that was due to continue<br>on a quarterly<br>basis|||||until|August|
|021 as a result||of Covid-19 impact||on the charity.||We are|in ongoing<br>discussions<br>with|||Moondance||
|oundation|on repurposing<br>part of this|||liability to fund||a specific|project proposal||which<br>may|reduce<br>this||
|utstanding|liability|in the future.||||||||||
|||||||Group|||Charity|||
|DEFERRED INCOME||||||2021||2020|2021||2020|
|||||||6|||f||6|
|Opening|Balance|||||122,790||17,271|46,108||17,271|
|Released|in the year|||||(214,363)||(99,850)|(146,753)||(99,850)|
|Deferred|in the year|||||225,058||205,389|197,578||128,687|
|Closing Balance||||||133,485||122,790|96,933||46,108|





## 

|0. FINANCIAL<br>INST|RUMEN|TS||||||
|---|---|---|---|---|---|---|---|
|||||Group||Charity||
|||||2021|2020|2021|2020|
|||||E|E|E|E|
|Financial assets measured||at|fair|||||
|value||||||||
|Investments||||4,022,759|2,940,386|4,022,759|2,940,386|
|||||4,022,759|2,940,386|4,022,759|2,940,386|
|Financial assets measured||at||||||
|amortised cost||||||||
|Trade debtors||||130,028|47,693|93,952|27,077|
|Other debtor transactions||||224,110|729,446|347,855|733,458|
|Cash||||1,048,822|102,242|959,555|24,113|
|||||1,402,960|879,381|1,401,362|784,648|
|Financial<br>liabilities|measured||at|||||
|arnortised<br>cost||||||||
|Bank overdraft|||||58,681||58,681|
|Trade creditors||||99,163|646,139|99,110|543,390|
|Other creditor transactions||||1,208,771|1,415,346|1,192,299|1,398,083|
|||||1,307,934|2,120,166|1,291,409|2,000,154|





|Notes to the|finan|cial statements|for the year|ended 31 Mar|ch 2021 —co|ntinued||
|---|---|---|---|---|---|---|---|
|21.FUNDS||||||||
|||Balance at|Income|Expenditure|Investment|Transfers|Balance at|
|||1 April 2020|||gains/<br>losses|between<br>Funds|31<br>March|
||||||E||2021|
||||||||E|
|Unrestricted||||||||
|General<br>Fund||2,676,645|6,201,137|(4,943,462)|673,479|(725,990)|3,861,809|
|Designated<br>Funds<br>Development<br>of||120,857||(4,337)|||116,520|
|Sustainable<br>Income||||||||
|Streams Fund||||||||
|Development<br>of||25,057||(25,057)||||
|Charitable<br>Activity||||||||
|Office Move Fund||27,853||(20,691)||32,838|40,000|
|Property Upgrade||90,000||||50,000|140,000|
|Fund||||||||
|Mobile Units|||150,000||||150,000|
|Community<br>insight||||||200,000|200,000|
|and Emotional<br>support||||||||
|Increased<br>Digitalisation<br>across||||||150,000|150,000|
|the Charity||||||||
|Lung Cancer<br>Screening<br>Fund||||||100,000|100,000|
|Retail Improvement||||||||
|Programme||||||200,000|200,000|
|Total Unrestricted||2,940,412|6,351,137|(4,993,547)|673,479|6,848|4,978,329|
|Restricted||||||||
|Equipment<br>Fund||13,855|3,910||||17,765|
|Mobile<br>Units<br>Capital||||||||
|Fund||1,002,590||(139,152)|||863,438|
|Mobile<br>Units<br>Running||||||||
|Costs Fund|||48,773|(91,675)||(970)|12,977|
|Research Fund|||6,000|||(6,000)||
|Retail Fund|||26,344|(1,200)|||25,144|
|Support Services|Fund|25,143|197,478|(110,376)|(2,993)||109,252|
|Support Groups Fund||62,853|24,585|(74,047)||(1,552)|11,839|
|Velindre<br>Fund||96,518||(101,487)||4,969||
|Job Retention Scheme|||1,250,012|(1,250,012)||||
|Fund||||||||
|Total Restricted||1,257,808|1,557,102|(1,767,949)|(2,993)|(3,553)|1,040,415|
|Total Charity||4,198,220|7,908,239|(6,761,496)|670,486|3,295|8,018,744|
|Total Subsidiary|(4a)|9,851|230,449|(229,654)||(3,295)|7,351|
|Total Group||4,208,071|8,138,688|(6,991,150)|670,486||8,026,095|





## 



## 

## 

## 



|Tenovus Cancer Care<br>Annual<br>Report &Accounts<br>Year Endin<br>31"INarch 2021|Tenovus Cancer Care<br>Annual<br>Report &Accounts<br>Year Endin<br>31"INarch 2021|Tenovus Cancer Care<br>Annual<br>Report &Accounts<br>Year Endin<br>31"INarch 2021|Tenovus Cancer Care<br>Annual<br>Report &Accounts<br>Year Endin<br>31"INarch 2021|||||65|
|---|---|---|---|---|---|---|---|---|
|Notes to the financial statements||||for the year|ended 31March|2021 - continued|||
|21.FUNDS -Comparative||Reserves|||||||
||Balance||Income||Expenditure|Investment|Transfers|Balance at 31|
||at 1|April||||gains/|between|March 2020|
||2019|||||losses|Funds||
|Unrestricted|||||||||
|General<br>Fund|3,683,657|||8,059,824|(8,657,673)|(285,363)|(123,800)|2,676,645|
|Designated<br>Funds|||||||||
|Development<br>of|125,792||||(4,935)|||120,857|
|Sustainable<br>Income|||||||||
|Streams<br>Fund|||||||||
|Development<br>of|72,629||||(47,572)|||25,057|
|Charitable<br>Activity|||||||||
|Office Move Fund|||||(10,480)||38,333|27,853|
|Property Upgrade|73,686||||(30,235)||46,549|90,000|
|Fund|||||||||
|Total Unrestricted|3,955,764|||8,059,824|(8,750,895)|(285,363)|(38,918)|2,940,412|
|Restricted|||||||||
|Campaign<br>fund||||3,308|(3,308)||||
|CSTActivity Fund||||13,744|(5,904)|||7,840|
|Equipment<br>Fund||17,487|||(3,632)|||13,855|
|Mobile Unit 1 Capital||9,242|||(1,411)||(5,929)|1,902|
|Fund|||||||||
|Mobile Unit 1—||89,316|||(13,134)||107,684|183,866|
|Redesign<br>Fund|||||||||
|Mobile Unit 2 Capital|186,325||||(38,550)|||147,775|
|Fund|||||||||
|Mobile Unit 3 Capital|748,538||||(79,491)|||669,047|
|Fund|||||||||
|Mobile Unit 2||||24,900|(9,385)|||15,515|
|Running<br>Costs Fund|||||||||
|Mobile Unit 3|189,786|||27,284|(163,236)|||53,834|
|Running<br>Costs Fund|||||||||
|Moondance<br>Fund|250,000||||(250,000)||||
|Research<br>Fund||||19,382|(19,382)||||
|Single Advice Fund||||22,126|(21,014)|||1,112|
|Specific Area Fund||4,367||5,435|(6,111)|||3,691|
|StJames Place||8,680|||(8,680)||||
|Fund|||||||||
|Support Groups||5,849||94,260|(44,084)||6,828|62,853|
|Fund|||||||||
|Welsh Government||||156,079|(156,079)||||
|Velindre<br>Fund|112,202||||(15,684)|||96,518|
|Total Restricted|1,621,792|||366,518|(839,085)||108,583|1,257,808|
|Total Charity|5,577,556|||8,426,342|(9,589,980)|(285,363)|69,665|4,198,220|
|Total Subsidiary||9,851||260,925|(191,260)||(69,665)|9,851|
|Total Group|5,587,407|||8,687,267|(9,781,240)|(285,363)||4,208,071|





## 

||General Funds|General Funds|Designated|Restricted Funds|Restricted Funds|Total|
|---|---|---|---|---|---|---|
||||Fundsf||E|31 March 2021<br>E|
|Charity|||||||
|Fixed/||756,286|||863,439|1,619,725|
|Intangible|||||||
|assets|||||||
|Investments||4,022,759||||4,022,759|
|Net assets/||(897,236)|1,096,520||176,976|376,260|
|(liabilities)|||||||
|||3,881,809|1,096,520||1,040,415|6,018,744|
|Group|||||||
|Fixed/||756,286|||863,439|1,619,725|
|Intangible|||||||
|assets|||||||
|Investments||4,022,759||||4,022,759|
|Net current||(889,885)|1,096,520||176,976|383,611|
|assets/-|||||||
|(liabilities)|||||||
|||3,889,160|1,096,520||1,040,415|6,026,095|
|23.ANALYSIS|OF|NET FUNDS|||||
||||1 April|2020|Cash flows|31 INarch|
|||||||2021|
|||||||6|
|Net cash analysed<br>in the|||||||
|balance sheet|||||||
|Cash at bank and||in hand|102,242||946,580|1,048,822|
|OverdraR|||(58,681)||58,681||
|Net funds|||43,561||1,005,261|1,048,822|





## 

## 

## 

## 

|t 31 Ma|rch 2021 th|e charit|y ha|d annual|commitments<br>un|der non-canc|ellable<br>operating<br>leases as f|ellable<br>operating<br>leases as f|
|---|---|---|---|---|---|---|---|---|
||||||Other||Land &Buildings||
||||||2021|2020|2021|2020|
||||||6|6|6|6|
|Expiring|within one|year|||22,084|32,044|784,663|1,001,680|
|Expiring|between|two|and|five|16,326|28,625|1,767,766|2,030,096|
|years|||||||||
|Expiring|in over five|years|||||681,337|548,640|
||||||38,410|60,669|3,233,766|3,580,416|





## 

## 



||||4I<br>N<br>Da0<br>0||0|Ol<br>CDn|||lll||CD<br>CO<br>CD<br>CD<br>CO<br>CLI<br>CD|CD<br>'ct<br>IO<br>CI<br>CLI|CO<br>Ol<br>~0<br>IO|||CLC<br>CO<br>~0<br>CO<br>IO<br>CD||||||LO<br>OI<br>IO||IO<br>CV<br>I||CD<br>IO<br>CLI|CD<br>CD<br>Cl<br>Ol|CD<br>CI<br>CLI|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||C||||||||||||||||||||||||||||
||||LD||||||||||||||||||||||||||||
||||E||||||||||||||||||||||||||||
||||al<br>N||e <br>N0|IO<br> IO<br>ca||||||LO<br>CI<br>CD|Ol<br>Ol<br>CD<br>'ct||CI<br>IO|Cl|||LO<br>CD|CI<br>CLI<br>LO<br>CD||CLL<br>CO||CLI<br>Cl<br>CI||||Ol|||
||||Ce||||||||||CD<br>IO|||CO<br>CO<br>Cl|||1|LO<br>CO||||CLI<br>Ol|||CO<br>CD|Ol<br>CI|||
||||00<br>Ia0||||||||||||||||||||||||||||
||||al<br>'0<br>alO.x<br>ID0C||D<br>N<br>e '0<br>al<br>&SI<br>U.<br>N<br>C<br>e<br>00<br>ID<br>Ci|||ID<br>C0<br>ee<br>CL0|Cll|||||||40<br>CI<br>CD||||||||||DD<br>CI<br>IYJ|40<br>Ol<br>ca||||
||||La||||||||||||||||||||||||||||
||||ID||||||||||||||||||||||||||||
||||E0<br>OC<br>Ol<br>C<br>N||'0<br>N<br>Ql<br>at '0 c<br>ZOC<br>» U. 40<br>N<br>C<br>Oo|||Ia<br>C0<br>Ia<br>al0.0|CII||IA<br>CI<br>CI<br>Cl<br>CO|IO<br>CI<br>CLI<br>CD||||40<br>ca<br>Cl|||CD<br>CI<br>CLI|||CD<br>CD|||||r<br>IO<br>Ca<br>IO|Cl<br>IO<br>ca|||
||||8C||||||||||||||||||||||||||||
||||CII<br>CO<br>N|||Ol 'D<br>'D<br>al<br>C<br>C<br>IL»C00<br>Ia||Ol<br>C0<br>CL0|CII||CD<br>CI<br>CO|||||Ol<br>CD<br>CI<br>Ca|||||||||||CD<br>CD<br>CI<br>CD||||
||||e<br>N<br>ID<br>al|||Ol<br>C|ol la<br>C<br>C0<br>C»<br>C<br>4I<br>0<br>CL<br>V 0||CII||CD<br>CLI<br>Ol<br>CI|||CLI<br>LO|CD<br>IO<br>YJ|CI<br>CO<br>CI<br>IO<br>Ol<br>I|||CD<br>CD<br>CLI|CD<br>CII<br>CD||Ol<br>LO<br>ca<br>CLI<br>I||Cl<br>CD<br>CD<br>CI||Cl<br>LO|CO<br>CI<br>CLI<br>IO<br>Cl<br>CCI|Cl<br>Cl<br>Ol<br>IO|||
||||0||||||||||||||||||||||||||||
||||Ol||||||||||||||||||||||||||||
||||ID||||||||||||||||||||||||||||
||||||e0||||||||||||||||||||||||||
||||al||||||||||||||||||||||||||||
||||O||||||||||||||||||||||||||||
||||La|||||||||||||||||||||||||ill|||
|N n<br>»0<br>c ca<br>OC<br>0 0<br>8 Ia<br>o42<br>» Ca<br>Sr<br>C 0<br>N 3,<br>VNC<br>C<br>g IODI<br>0c c al<br>OCO<br>I-c(&||N<br>C<br>E<br>8<br>00<br>la<br>QCIaC<br>IL|LL<br>0<br>C<br>alE<br>al<br>al<br>N<br>N0<br>Ca<br>ONN<br>L C<br>0 'ca<br>O<br>CD|||||||I-Z<br>0<br>CiZ<br>OI<br>0Z<br>oo<br>Z IL|Ine<br>Q<br>0(l<br>C0eC0<br>Ci|N4I<br>0<br>e<br>T)8<br>e<br>O|OIal<br>CD<br>C<br>La<br>e<br>0|Ol<br>C<br>al<br>E<br>Ne<br>C|ID|0VZ<br>I0I-|Z0<br>I-<br>CiZ<br>IU<br>IL<br>Ul|Ol<br>C<br>U.<br>Cl<br>C<br>Ol<br>al|Nal6e<br>Ol<br>4l<br>oa<br>NC0<br>C00|ID<br>Ol<br>C0<br>I-<br>4l<br>0|Nal<br>0<br>Tl8<br>Ia<br>0<br>0<br>N0o|Qee<br>Ne <br>0<br>La <br>0E|In<br> o<br>OI<br>C<br> e<br> P|ID<br>CO<br>ee<br>CL|CL<br>0<br>U<br>0<br>Ot.<br>CL<br>lo|0<br>CL<br>Og<br>In<br>OleO.E<br>caO|IU<br>IL<br>I<br>CiZ<br>Ul0<br>IU<br>I-0|I-0 e<br>Z<br>UI e<br>In<br>IL<br>N<br>ID<br>ONOIe<br>BU 0<br>I- o<br>ao<br>UI e x<br>Zo e|||





|||8||r<br>CO<br>CI<br>CV|CIoo<br>IO|CO<br>OI<br>CD<br>IO<br>CV||||||Cl<br>IO<br>IO<br>EO<br>CO<br>CC||CO<br>CO<br>Ol<br>CV<br>~0<br>Cl<br>IO||rCl<br>IO<br>Irl||C<br>m <br>c<br>VJ|L<br> 0<br>mD<br>m<br>m<br> 0.||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||E-<br>V0||||||||||||||||0|IC9||
|||C||||||||||||||||CEI|||
|||Ct||||||||||||||||OI|||
|||E||||||||||||||||ECJ"|nl||
|||CI<br>10C||Ol<br>OI<br>CO||04<br>ICI<br>00||||||CO<br>CJI<br>~0<br>Ol<br>~JI||ECI<br>~O||r<br>00<br>CI<br>CV||IO<br>CII<br>CD|m<br> I-||
|||m||||||||||||EO|||||In||
|||C<br>O0<br>O<br>m||||||||||||||||CD <br>CII<br>EV|In<br> 0<br>CO<br>IO<br>EO||
|||m||||||||||||||||00|EA||
||||||||||||||||||||CII||
|||YlC<br>CJ||||||||||||||||CJJ|CYJ||
|||CL<br>CJX<br>Tl||||||||||||||||0|CO<br> CI<br>CEI||
||CI|||||||||||||||||tn|||
|||ID<br>mE0<br>O<br>Pl<br>C||||IO<br>IO<br>CV|CO<br>EO<br>CO<br>CI|||||||C4<br>CD<br>or<br>EO||00<br>CI<br>CO<br>IO<br>04||IDW <br>e|IO<br>YJ<br>PJ||
|||0|||||||||||||||||||
|||CL|||||||||||||||||N||
|||O0<br>C<br>CI||||||||||||||||4J <br>0.<br>IC|In<br> 0<br>4IL||
|||CII<br>CI<br>CC||||||||||||||||mE|4I<br>CD||
|||O<br>L||||||||||||||||8<br>.E|&<br>CD||
|||m|||||||||||||||||||
||||||||||||||||||||CI||
|||||||||||||||||||m|||
||||||||||||||||||||In||
|||FJ|||||||||||||||||nl||
||||||||||||||||||||m||
|||m0L<br>CJ<br>I<br>ID<br>ID||CD<br>44<br>CO<br>CD<br>CV||IO<br>EO<br>Ol<br>EO~I<br>CD|CO<br>00<br>IO<br>Cl~I|||||04<br>EO<br>CO<br>IO<br>CI||IO<br>CO<br>IO<br>CO<br>Ol||EO<br>CO<br>IO<br>CD||'C<br>CE|0I<br>IC<br>0||
|||ID||||||||||||CO||CC|||||
|||N<br>4J||||||||||||CV<br>CV||OC||0E <br>0.|c0<br> C||
||||||||C4|||||||T<br>CC|||||mpl||
|||||||||||||||||||N|o~||
|N C4<br>v0<br>C CV<br>OC<br>0 O<br>0<br>Cl<br>oCR<br>~- 05I<br>OCn<br>0e.h<br>N IC '0<br>C<br>Cl IU<br>OOJ<br>CCN<br>CI C 4I||m<br>OC<br>ED<br>IL<br>CJ<br>E<br>8<br>III<br>m<br>4I<br>Tl<br>0<br>nlC00|ID<br>4I<br>In<br>CI0<br>13C<br>ID<br>nl<br>mpl|8<br>m<br>E<br>N<br>Cl<br>C<br>L0<br>N0I<br>nlIn0<br>nl<br>ITI<br>CD<br>mZ|In<br>0<br>IDC0<br>CL<br>4IO<br>IU|IL'<br>I<br>CiZ<br>IU<br>IL<br>i0Z0<br>OZ|C<br>m<br>m<br>C<br>In|Ci<br>IU<br>CO<br>Z0 <br>0 <br>O <br>UI <br>& <br>Z <br>I-<br>0|00<br> rn<br> 00<br> 0<br> (a<br> Z<br>cL'<br>0|m<br>ECo<br>0<br>mN0<br>CE<br>N<br>L0<br>In<br>mNN0<br>NL|N<br>mIn<br>In|CO0Z0<br>Z<br>I-Z<br>IUE<br>IU<br>0Z<br>I<br>IUZ|OI<br>CiZ0<br>Z<br>Z0<br>0Z0V<br>IU<br>IL|0v<br>Ol<br>0<br>D<br>ID<br>Cl0 <br>m <br>ID<br>D<br>C<br>IL|o<br> 04<br>'E<br>?L<br>m|0<br>'CI<br>4I<br>'L<br>ID" <br>N <br>m<br>C<br>Ol<br>C<br>U|CC<br> o<br>c4<br>I<br>m<br>CD<br>m|.m co<br>7<br>CEI<br>ID<br>CL CD<br>E ~<br>0<br>CO<br>U<br>CEI<br>0<br>S. CEI I<br>c<br>)<br>4I<br>N mc<br>N<br>L<br>0 pv-0<br>m D<br>D'0<br>L<br>I<br>m<br>m|||





## 

## 



## 



## 

